Michael Arzt Selected Research

Sleep Apnea Syndromes (Sleep Apnea)

2/2022	Enhanced Cardiac CaMKII Oxidation and CaMKII-Dependent SR Ca Leak in Patients with Sleep-Disordered Breathing.
12/2021	Sleep-disordered breathing is independently associated with reduced atrial connexin 43 expression.
4/2021	Sleep apnoea and incident malignancy in type 2 diabetes.
1/2021	Long-Term Weight Change and Glycemic Control in Patients With Type 2 Diabetes Mellitus and Treated vs. Untreated Sleep-Disordered Breathing-Analysis From the DIAbetes COhoRtE.
1/2021	Female Patients With Sleep-Disordered Breathing Display More Frequently Heart Failure With Preserved Ejection Fraction.
1/2021	The Effect of Gender and Sex Hormones on Cardiovascular Disease, Heart Failure, Diabetes, and Atrial Fibrillation in Sleep Apnea.
1/2021	Central Sleep Apnea Predicts Pulmonary Complications After Cardiac Surgery.
1/2020	Enhanced CaMKII-Dependent Late INa Induces Atrial Proarrhythmic Activity in Patients With Sleep-Disordered Breathing.
1/2020	Cooperation Between Hypoxia-Inducible Factor 1α and Activating Transcription Factor 4 in Sleep Apnea-Mediated Myocardial Injury.
9/2019	Nightly sleep apnea severity in patients with atrial fibrillation: Potential applications of long-term sleep apnea monitoring.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Michael Arzt Research Topics

Disease

20	Sleep Apnea Syndromes (Sleep Apnea) 02/2022 - 12/2005
18	Heart Failure 12/2021 - 03/2005
9	Apnea 12/2021 - 06/2007
9	Central Sleep Apnea (Central Sleep Apnea Syndrome) 06/2021 - 06/2006
7	Obstructive Sleep Apnea 01/2022 - 06/2006
7	Atrial Fibrillation 12/2021 - 01/2017
6	Myocardial Infarction 01/2022 - 01/2014
4	Cheyne-Stokes Respiration 06/2021 - 07/2008
4	Chronic Obstructive Pulmonary Disease (COPD) 01/2021 - 01/2008
3	Stroke (Strokes) 01/2022 - 12/2005
3	Infarction (Infarctions) 07/2021 - 01/2014
3	Hypoxia (Hypoxemia) 01/2020 - 02/2003
3	Sleep Deprivation 05/2018 - 01/2016
2	Cardiovascular Diseases (Cardiovascular Disease) 01/2021 - 12/2020
2	Erectile Dysfunction 09/2020 - 01/2019
2	Diabetes Mellitus 01/2020 - 01/2017
2	Cardiac Arrhythmias (Arrythmia) 01/2018 - 01/2017
2	Disease Progression 01/2017 - 01/2011
2	Pulmonary Hypertension 01/2010 - 02/2003
1	Disorders of Excessive Somnolence (Hypersomnia) 01/2022
1	Pain (Aches) 07/2021
1	Type 2 Diabetes Mellitus (MODY) 01/2021
1	Iron Deficiencies 01/2021
1	Weight Gain 01/2021
1	Coronary Artery Disease (Coronary Atherosclerosis) 12/2020
1	Coronary Disease (Coronary Heart Disease) 12/2020
1	Atrial Premature Complexes (Premature Atrial Contraction) 01/2020
1	Systolic Heart Failure 01/2020
1	Delirium 01/2019
1	Heart Diseases (Heart Disease) 05/2018
1	ST Elevation Myocardial Infarction 01/2017
1	Nervous System Diseases (Neurological Disorders) 01/2017
1	Kidney Diseases (Kidney Disease) 01/2017
1	Myocardial Ischemia (Ischemic Heart Diseases) 07/2015
1	Lung Diseases (Lung Disease) 10/2014
1	Pulmonary Sarcoidosis 01/2011
1	Right Ventricular Hypertrophy 01/2010
1	Pulmonary Fibrosis (Fibrosing Alveolitis) 01/2010
1	Obesity Hypoventilation Syndrome (Pickwickian Syndrome) 01/2008
1	Vascular Remodeling 02/2003

Drug/Important Bio-Agent (IBA)

7	Oxygen (Dioxygen)IBA 12/2021 - 03/2005
3	Calcium-Calmodulin-Dependent Protein Kinase Type 2IBA 02/2022 - 01/2020
3	Messenger RNA (mRNA)IBA 12/2020 - 02/2003
2	Antihypertensive Agents (Antihypertensives)IBA 12/2020 - 09/2020
2	Brain Natriuretic Peptide (Natrecor)FDA Link 01/2020 - 01/2018
2	CreatinineIBA 01/2020 - 01/2017
2	Opioid Analgesics (Opioids)IBA 01/2018 - 01/2017
1	Oxidants (Oxidizing Agents)IBA 02/2022
1	pitolisantIBA 01/2022
1	Connexin 43 (Connexin43)IBA 12/2021
1	ConnexinsIBA 12/2021
1	Gonadal Steroid Hormones (Sex Hormones)IBA 01/2021
1	HematinicsIBA 01/2021
1	Insulin (Novolin)FDA Link 01/2021
1	IronIBA 01/2021
1	Natriuretic PeptidesIBA 01/2021
1	sacubitril and valsartan sodium hydrate drug combinationIBA 01/2021
1	Spironolactone (Aldactone)FDA LinkGeneric 01/2021
1	Angiotensin Receptor AntagonistsIBA 12/2020
1	HDL LipoproteinsIBA 12/2020
1	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 12/2020
1	Angiotensin-Converting Enzyme 2IBA 12/2020
1	KN 93IBA 01/2020
1	Polytetrafluoroethylene (Teflon)FDA Link 01/2020
1	Proteins (Proteins, Gene)FDA Link 01/2020
1	CCAAT-Enhancer-Binding ProteinsIBA 01/2020
1	Activating Transcription Factor 4IBA 01/2020
1	pro-brain natriuretic peptide (1-76)IBA 01/2018
1	Carbon DioxideIBA 11/2017
1	GasesIBA 11/2017
1	AlbuminsIBA 01/2017
1	aclidinium bromideIBA 01/2017
1	Carbon MonoxideIBA 01/2011
1	Endothelins (Endothelin)IBA 01/2010
1	Bleomycin (Blenoxane)FDA LinkGeneric 01/2010
1	Bosentan (Tracleer)FDA Link 01/2010
1	Endothelin Receptor AntagonistsIBA 01/2010
1	Biomarkers (Surrogate Marker)IBA 12/2005
1	Nitric Oxide Synthase Type III (Endothelial Nitric Oxide Synthase)IBA 02/2003
1	darusentanIBA 02/2003

Therapy/Procedure

16	Therapeutics 01/2022 - 10/2014
13	Continuous Positive Airway Pressure 09/2020 - 03/2005
5	Coronary Artery Bypass (Coronary Artery Bypass Surgery) 10/2021 - 01/2018
4	Percutaneous Coronary Intervention 07/2021 - 07/2015
2	Length of Stay 01/2019 - 12/2018
1	Occlusal Splints 01/2022
1	Electric Countershock (Cardioversion) 01/2021
1	Glycemic Control 01/2021
1	Catheter Ablation 01/2021
1	Catheters 01/2021
1	Implantable Defibrillators (Implantable Cardioverter-Defibrillator) 01/2017
1	Artificial Respiration (Mechanical Ventilation) 11/2011
1	Stroke Rehabilitation 03/2010
1	Noninvasive Ventilation 01/2008